|
Product complaint: (b)(4).Date sent to the fda: 9/21/2026.H6 component code: g07002 - no device problem found.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent:
our failure analysis lab received extra products with reference to this complaint; we received:
extra device received:
product code: (13) (b)(4).Product batch / lot : 10ehpd.1.Could you please clarify if extra device belongs to this complaint?
2.If not, could you please clarify if the extra received product belongs to a different complaint? if so, can you please provide the complaint number.3.If the device was not reported before, please provide more details of device malfunction.4.If the product doesn¿t belong to any complaint, please let us know so we can discard it or advise if the product is required to be returned.5.If you have the correct complaint product in your possession, please forward the product to ethicon as soon as possible.If you have already sent the product to ethicon, please reply to productcomplaint1@its.Jnj.Com with the ups, dhl or fedex tracker number.Additional information was requested, the following was obtained:
¿ was evarrest product involved? no, i accidentally typed evarrest but meant prolene.¿ if so, please provide product code and lot number: the product code and lot number are in the package that i shipped back and on the form.(b)(4) and lot 10e13c.¿ how many devices demonstrated the alleged deficiency? unsure the exact number ¿ 2-3 based on previous conversations.¿ did the event occur during one or multiple patient procedures? multiple.¿ what is the total number of procedures? unsure.¿ have any of these events been previously reported to ethicon? if so, could you please provide the corresponding reference number(s)? unsure, but i do not think so.¿ did this issue contribute to any patient adverse event? unsure.¿ please provide the source or name and title of external person providing answers to follow-up (external person submitting answers to sales rep) k o's.H3 investigational summary: the product was returned to ethicon for evaluation.Five (5) representative unopened samples were received for analysis.Product code (b)(4).The complaint sample was not received for evaluation.Upon initial inspection of the samples, no external damages were observed on the external packets.In order to evaluate the condition of the returned samples, the packets were opened, and the swage and attachment area were noted to be as expected.The sutures were dispensed without problems and examined along the strand to detect any issue related to the customer complaint and no defects were observed during evaluation.A functional test was performed using instron equipment and tensile force was above the minimum requirements.The event described could not be confirmed as the device performed without any defect noted.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.The event described could not be confirmed as no product defect was identified, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the laboratory analysis.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.
|